Curious incentives on display. The Food and Drug Administration just granted permission for “expanded access” to an experimental medicine for Ebola. It’s OK as far as it goes, but it’s an exception to the FDA’s reluctance to approve the use of life-saving products. Safety and efficacy testing of the drug, designated TKM-Ebola, has barely ... MOREHenry I. Miller: Life-Saving Drugs And Deadly Delays
Curious incentives on display. The Food and Drug Administration just granted permission for “expanded access” to an experimental medicine for Ebola. It’s OK as far as it goes, but it’s an exception to the FDA’s reluctance to approve the use of life-saving products. Safety and efficacy testing of the drug, designated TKM-Ebola, has barely ... MORE